News | December 03, 2006

Docs Should Alert ICD/Pacemaker Patients About Magnets

Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”

A release from the Heart Rhythm Society reports that researchers found that while common magnets for home and office use with low magnetic strength posed little risk, stronger magnets made from neodymium-iron-boron (NdFeB) may cause interference with cardiac devices and pose potential hazards to patients. NdFeB magnets are increasingly being used in homes and office products, toys, jewelry and even clothing.

“Physicians should caution patients about the risks associated with these magnets,” says Thomas Wolber, a cardiologist at the University Hospital of Zurich in Switzerland and lead author of the study. “We also recommend that the packaging include information on the potential risks that may be associated with these types of magnets.”

Two spherical magnets of eight and 10 millimeters in diameter and one necklace made of 45 spherical magnets were tested on 70 patients, 41 with pacemakers and 29 with ICDs. Magnetic interference was observed in all patients. The cardiac devices resumed normal function after the magnets were removed.

“This study is timely and important to attract the attention of both the public and the medical profession about the potentially serious health consequences of magnets used in decoration products... for an ICD patient, the magnet interference can be fatal,” writes Huagui Li, M.D., a cardiologist at the Minnesota Heart Clinic in Edina, MN, in an accompanying “Heart Rhythm” editorial.

Dr. Li concludes that manufacturers who use magnets should be required to put warning labels on their products for optimal patient safety.


Related Content

News | Cardiovascular Clinical Studies

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Home
News | Cardiovascular Clinical Studies

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results ...

Home May 17, 2024
Home
News | Cardiovascular Clinical Studies

May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...

Home May 15, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the ...

Home May 14, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — An ambitious, nationwide clinical trial led by UVA Health’s Karen Johnston, MD, has provided doctors with ...

Home May 14, 2024
Home
News | Cardiovascular Clinical Studies

May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms ...

Home May 13, 2024
Home
News | Cardiovascular Clinical Studies

May 13, 2024 — Even though mortality and hospitalization rates have improved, the quality of life for those living with ...

Home May 13, 2024
Home
News | Cardiovascular Clinical Studies

May 10, 2024 — Scientists from Immanuel Kant Baltic Federal University proved that Raman spectroscopy, a method by which ...

Home May 10, 2024
Home
Subscribe Now